News
Find out about the latest news from Oxford Gene Technology.
"FISH" news stories:
- 30 January 2019
FDA grants de novo designation for OGT’s AML/MDS FISH probes
Clearance enables accurate and easy-to-interpret AML and MDS detection with reduced validation burden
- 8 November 2018
OGT further expands global direct sales and support into Asia-Pacific
Following successful European rollout, more customers to benefit from enhanced local sales and support services.
- 2 July 2018
OGT expands direct sales and support infrastructure in Europe
Customers to benefit from Sysmex’s extensive operational footprint
- 7 March 2018
OGT enhances customer experience with new Cytocell website
OGT has launched a new version of its Cytocell® fluorescence in situ hybridisation (FISH) probes website.
- 15 December 2016
OGT expands Cytocell sarcoma FISH probe range
Addition of three new sarcoma probes produces largest portfolio on the market
- 22 November 2016
OGT announces commercial and financial highlights for FY 2016
Highly integrated molecular genetics portfolio delivers significant revenue growth and sustainable profit
- 11 October 2016
Customer input drives expansion of Cytocell Aquarius Haematology range
- 13 September 2016
OGT expands Cytocell FISH probe portfolio for lung cancers
- 21 June 2016
OGT launches 9 new Cytocell Aquarius FISH probes
- 4 May 2016
OGT launches Cytocell FISH probes for glial tumours
- 13 April 2016
OGT develops new FISH probes in ‘outstanding’ Innovate UK project
- 10 December 2015
OGT announces commercial and financial highlights for FY 2015
- 28 July 2015
OGT expands its portfolio of Cytocell pathology FISH probes
- 2 December 2014
OGT announces operational and financial highlights for FY 2014
- 9 October 2014
OGT named OBN’s Best Medtech Dealmaker
Find out more
For more information about any OGT product or service, please contact us.